Literature DB >> 20505437

Serum nitrosative stress levels are increased in Alzheimer disease but not in vascular dementia.

Konukoğlu Dildar1, Firtina Sinem, Erkol Gökhan, Yağiz Orhan, Manga Filiz.   

Abstract

The aim of this study was to investigate whether there is a difference between Alzheimer disease (AD) dementia and pure vascular dementia (VaD) in relation to nitrosative stress levels. We determined serum nitric oxide (NO), oxidized low-density lipoproteins (ox-LDL), and 3-nitrotyrosine levels (3-NT) in healthy elderly individuals (controls, n=15, mean age=73.4+/-7.9 y), AD patients (n=30; mean age=71.2+/-12.7 y) and VaD patients (n=20; mean age=75.2+/-7.5 y). Patients were under anticholinesterase drug therapy. Our results showed that serum NO and ox-LDL levels in AD patients group were significantly higher than in both controls (P<0.001 and P<0.001) and VaD patients (P<0.01 and P<0.001). However, no significant differences in plasma NO and ox-LDL levels were found between VaD and controls. Our study did not reveal significant differences in plasma 3-NT values of dementia patients when compared with controls. There was a significant negative correlation between Mini-Mental State Examination score and serum NO levels in dementia patients (r=-0.349, P<0.01). Serum NO levels were also positively correlated with serum ox-LDL levels (r=0.358, P<0.01). In conclusion, elevation in serum levels of NO was present in probable AD patients but not in VaD patients, and this seems to be related to both ox-LDL levels and cognitive status.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20505437     DOI: 10.1097/WAD.0b013e3181c53d0d

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  5 in total

Review 1.  Clinical Relevance of Biomarkers of Oxidative Stress.

Authors:  Jeroen Frijhoff; Paul G Winyard; Neven Zarkovic; Sean S Davies; Roland Stocker; David Cheng; Annie R Knight; Emma Louise Taylor; Jeannette Oettrich; Tatjana Ruskovska; Ana Cipak Gasparovic; Antonio Cuadrado; Daniela Weber; Henrik Enghusen Poulsen; Tilman Grune; Harald H H W Schmidt; Pietro Ghezzi
Journal:  Antioxid Redox Signal       Date:  2015-10-26       Impact factor: 8.401

Review 2.  The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.

Authors:  Eugenio Barone; Fabio Di Domenico; Cesare Mancuso; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2013-10-02       Impact factor: 5.996

3.  Nitrosative Stress in the Frontal Cortex From Dogs With Canine Cognitive Dysfunction.

Authors:  Sonja Prpar Mihevc; Maja Zakošek Pipan; Malan Štrbenc; Boris Rogelj; Gregor Majdič
Journal:  Front Vet Sci       Date:  2020-11-19

4.  Biochemical Discrimination of the Down Syndrome-Related Metabolic and Oxidative/Nitrosative Stress Alterations from the Physiologic Age-Related Changes through the Targeted Metabolomic Analysis of Serum.

Authors:  Giacomo Lazzarino; Angela M Amorini; Renata Mangione; Miriam Wissam Saab; Enrico Di Stasio; Michelino Di Rosa; Barbara Tavazzi; Giuseppe Lazzarino; Graziano Onder; Angelo Carfì
Journal:  Antioxidants (Basel)       Date:  2022-06-20

5.  Evaluation of neural gene expression in serum treated embryonic stem cells in Alzheimer's patients.

Authors:  Leila Dehghani; Batool Hashemi-Beni; Elahe Poorazizi; Fariborz Khorvash; Vahid Shaygannejad; Maryam Sedghi; Sahar Vesal; Rokhsareh Meamar
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.